Lidocaine enhances intraoperative ventricular defibrillation

Area of Science:

• Cardiology
• Cardiac Surgery
• Pharmacology

Background:

• Myocardial reperfusion following cardiac surgery can lead to electrical instability.
• Defibrillation is often required to manage arrhythmias during this critical period.
• Optimizing defibrillation protocols is crucial for patient outcomes.

Purpose of the Study:

• To evaluate the efficacy of lidocaine in reducing defibrillation requirements during myocardial reperfusion.
• To assess the impact of lidocaine on the number, energy, and current of direct current (DC) shocks needed for defibrillation.

Main Methods:

• A randomized controlled trial involving 20 patients undergoing coronary artery bypass surgery.
• Patients were assigned to a control group or a group receiving intravenous lidocaine before and during aortic unclamping and cardiac reperfusion.
• Continuous electrocardiogram (ECG) monitoring and recording of defibrillation parameters (number, energy, current) were performed.

Main Results:

• Lidocaine infusion significantly decreased the number of low-energy DC shocks required for sustained defibrillation (5.5 vs 3.5, P < 0.05).
• The energy of DC shocks also decreased significantly in the lidocaine group (11.0 vs 5.6 joules, P < 0.05).
• Plasma electrolytes, blood gases, myocardial temperature, and surgical techniques were similar between groups, indicating lidocaine as the primary factor.

Conclusions:

• Lidocaine administration during myocardial reperfusion facilitates defibrillation with fewer and lower-energy direct current (DC) shocks.
• Lidocaine may improve electrical stability and reduce the need for aggressive electrical interventions post-reperfusion.
• These findings support the use of lidocaine as an adjunct therapy in cardiac surgery to manage reperfusion-related electrical events.